Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system

• Main Authors: Huqun Li (Author), Chongshu Wang (Author), Cuilian Guo (Author)
• פורמט: ספר
• יצא לאור: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

BackgroundLorlatinib displays marked systemic and intracranial efficacy against anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC). We aimed to establish the safety profile of lorlatinib based on the Food and Drug Administration Adverse Event Reporting System (FAERS).Method...